Carvedilol Bis-carbazole,
918903-20-5,
Carvedilol Related Compound B,
TCMDC-141980,
Carvedilol Biscarbazole,
1,1'-((2-(2-Methoxyphenoxy)ethyl)nitrilo)bis(3-(9H-carbazol-4-yloxy)propan-2-ol),
Carvedilol impurity B [EP],
1,1'-[[2-(2-Methoxyphenoxy)ethyl]nitrilo]bis[3-(9H-carbazol-4-yloxy)propan-2-ol],
1-(9H-carbazol-4-yloxy)-3-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]-[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol,
Carvedilol related compound B [USP],
Carvedilol Impurity B,
CHEMBL580661,
SCHEMBL4555826,
CTK8E9003,
(+/-)-3,3'-(2-(2-Methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol),
2-Propanol, 1,1'-((2-(2-methoxyphenoxy)ethyl)imino)bis(3-(9H-carbazol-4-yloxy)-,
3,3'-(2-(2-Methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol),
RT-011922,
FT-0664399,
1,1'-[[2-(2-Methoxyphenoxy)ethyl]imino]bis[3-(9H-carbazol-4-yloxy)-2-propanol,
4-[2-(2-Methoxyphenoxy)ethyl]-1,7-bis(9H-carbazole-4-yloxy)-4-azaheptane-2,6-diol,
Carvedilol Related Compound B, United States Pharmacopeia (USP) Reference Standard,
1,1'-{[2-(2-Methoxyphenoxy)ethyl]nitrilo}bis[3-(9H-carbazol-4-yloxy)-propan-2-ol], pharmaceutical impurity standard,
Carvedilol Biscarbazole (1,1'-[[2-(2-Methoxyphenoxy)ethyl]nitrilo]-bis[3-(9H-carbazol-4-yloxy)propan-2-ol]),
Carvedilol EP Impurity B,
UNII-56RX0K2UL0,
56RX0K2UL0,
CS-O-07545,